P
Patheous Health
Onsite dysphagia imaging, diagnostic, and education services
About Patheous Health
Patheous Health provides mobile dysphagia diagnostic and imaging services for healthcare facilities, focusing on senior care. The company was co-founded by CEO Michael Peck and COO Correy Trupp and is headquartered in Overland Park, Kansas. Patheous Health was founded in 2019 and has since grown through a series of acquisitions and funding rounds, including a Series A in March 2020 and a Series B led by NewSpring Capital in April 2023.
The company's core business revolves around its Integrated Dysphagia Healthcare (iDH) platform, which delivers mobile swallow studies directly to patients at their care facilities. This model is designed to reduce healthcare costs, improve patient outcomes by providing care in a familiar environment, and eliminate the need for patient transport. Key services include Modified Barium Swallow (MBS) studies and Fiberoptic Endoscopic Evaluation of Swallowing (FEES), which provide real-time diagnoses of swallowing impairments. The primary clients are skilled nursing facilities and senior care organizations.
Patheous Health has pursued an aggressive growth strategy, acquiring several companies to expand its geographic footprint and service capabilities. Notable acquisitions include MBS Envision, Carolina Speech Pathology (a major provider of mobile FEES studies), SuperiorView Swallow Diagnostics, MBS Advantage, and Midwest Dysphagia Diagnostics. In March 2024, the company consolidated these brands to operate under the single name Patheous Health to streamline operations and unify its services across 18 states. In addition to diagnostic services, the company offers continuing education, mentorship programs, and training for healthcare professionals.
Source: Dealroom company dataNews
Open roles
Patheous Health in the Overland Park ecosystem
The Patheous Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
NewSpring Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Patheous Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Patheous Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

